Clinical Trials Logo

Structural Heart Disease clinical trials

View clinical trials related to Structural Heart Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02737969 Completed - Clinical trials for Structural Heart Disease

TEE/Angio Fusion Study

Start date: April 2016
Phase:
Study type: Observational

This is a pilot study of patients undergoing structural heart disease procedures that utilize TEE and fluoroscopic guidance at the New York University (NYU) Langone Medical Center. Patients in this study will undergo their procedure utilizing the TEE/Angio fusion software prototype. This protocol is primarily intended to ascertain the potential utility of the software prototype in the study population and to provide data and feedback to improve the workflow and algorithms of the prototype. As such, a primary outcome variable and statistical analysis plan have not been identified. However, procedural time, measures of radiation exposure (dose area product, total radiation dose, fluoroscopy time), degree of residual valvular regurgitation or paravalvular regurgitation as applicable, and complications will be recorded.

NCT ID: NCT00564122 Completed - Clinical trials for Congenital Heart Disease

The Accuracy of an Artificially-intelligent Stethoscope

Start date: December 2007
Phase: N/A
Study type: Observational

This study will characterize the accuracy of a commercially available artificially-intelligent stethoscope in determining which childhood murmurs suggest underlying congenital structural heart disease and therefore warrant diagnostic echocardiograms.

NCT ID: NCT00380016 Completed - Clinical trials for Structural Heart Disease

Catheter-Based Treatment of Cardiovascular Disease

Start date: September 20, 2006
Phase: N/A
Study type: Interventional

This study offers catheter-based treatment of heart or artery disease. This protocol permits treatment of patients with cardiovascular diseases who may not be eligible to participate in current research protocols. The treatment offered in this protocol is not experimental, but rather standard treatment provided in most large referral hospitals in the United States. Patients 18 years of age and older who are candidates for catheter-based treatment of obstructive artery disease, including blocked blood flow in a coronary artery (artery to the heart) or in an artery of the arm, leg, brain or kidney may be eligible for this study. Candidates are screened with a general medical evaluation that may include blood tests, magnetic resonance imaging, and monitoring of heart rate and rhythm. Participants undergo angioplasty or stenting for blockage in an artery to the heart or an artery of the arm, leg, brain or kidney. The procedure uses a balloon-tipped catheter to open the blocked artery and likely requires permanent implantation of a metal tube (stent) to improve blood flow through the vessel. During the procedure, the patient is given a sedative and pain medication, if needed.